Inhibikase Therapeutics, Inc. (IKT) insider trading
Over the last 12 months, 1 insider bought $3.00M and 0 insiders sold $0 of Inhibikase Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Nov 21, 2025: Sands Capital Alternatives, LLC bought 2,068,965 shares ($3.00M)